Journal
JOURNAL OF NEUROCHEMISTRY
Volume 142, Issue -, Pages 26-40Publisher
WILEY
DOI: 10.1111/jnc.14026
Keywords
acetylcholinesterase; bioscavenger; nerve agent; organophosphate poisoning; oxime; post-exposure treatment; prophylaxis
Categories
Funding
- Russian Government
Ask authors/readers for more resources
Organophosphorus agents (OPs) irreversibly inhibit acetylcholinesterase (AChE) causing a major cholinergic syndrome. The medical counter-measures of OP poisoning have not evolved for the last 30 years with carbamates for pretreatment, pyridinium oximes-based AChE reactivators, antimuscarinic drugs and neuroprotective benzodiazepines for post-exposure treatment. These drugs ensure protection of peripheral nervous system and mitigate acute effects of OP lethal doses. However, they have significant limitations. Pyridostigmine and oximes do not protect/reactivate central AChE. Oximes poorly reactivate AChE inhibited by phosphoramidates. In addition, current neuroprotectants do not protect the central nervous system shortly after the onset of seizures when brain damage becomes irreversible. New therapeutic approaches for pre- and post-exposure treatments involve detoxification of OP molecules before they reach their molecular targets by administrating catalytic bioscavengers among them phosphotriesterases are the most promising. Novel generation of broad spectrum reactivators are designed for crossing the blood brain barrier and reactivate central AChE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available